Stealth BioTherapeutics (MITO) Short Interest Ratio & Short Volume

Short interest is the volume of Stealth BioTherapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 193,100 shares of MITO short. Learn More on Stealth BioTherapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MITO shares currently have a short interest ratio of 1.0. Learn More on Stealth BioTherapeutics's short interest ratio.

Stealth BioTherapeutics saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 193,100 shares, a decline of 29.2% from the previous total of 272,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Stealth BioTherapeutics: Oncternal Therapeutics, Inc. (0.52%), CytoMed Therapeutics Limited (0.99%), Cumberland Pharmaceuticals Inc. (0.22%), Biora Therapeutics, Inc. (4.33%), Bullfrog AI Holdings, Inc. (5.49%), Lumos Pharma, Inc. (5.83%), Enlivex Therapeutics Ltd. (1.50%), Synlogic, Inc. (0.53%), MEI Pharma, Inc. (0.34%), Sensei Biotherapeutics, Inc. (0.50%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.81 billion), Charter Communications, Inc. ($3.04 billion), T. Rowe Price Group, Inc. ($1.98 billion), PG&E Co. ($1.92 billion), Lucid Group, Inc. ($1.90 billion), Coinbase Global, Inc. ($1.75 billion), Roblox Co. ($1.58 billion), Rivian Automotive, Inc. ($1.54 billion), Diamondback Energy, Inc. ($1.53 billion), and Old Dominion Freight Line, Inc. ($1.47 billion). View all of the most shorted stocks.

Short selling MITO is an investing strategy that aims to generate trading profit from Stealth BioTherapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Stealth BioTherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MITO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MITO, twice per month. The most recent reporting period available is October, 31 2022.